Phospholamban and cardiac contractility

被引:98
作者
Frank, K [1 ]
Kranias, EG [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA
关键词
cardiac contractility; phospholamban; relaxation; sarcoplasmic reticulum;
D O I
10.3109/07853890008998837
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Over the last three decades, our knowledge and understanding of the role of phospholamban and its modulation of sarcoplasmic reticulum (SR) function has advanced significantly. Phospholamban is a key regulator of cardiac contractility and modulates SR Ca2+ sequestration by inhibiting the SR Ca2+ -ATPase (SERCA) in its dephosphorylated state. Upon phosphorylation, which is mediated through beta -adrenergic stimulation, the inhibitory effect of phospholamban on the function of SERCA is relieved. This review summarizes recent advances that have been made towards understanding the modulation of SR Ca2+-sequestration by phospholamban through the generation and characterization of genetically altered animal models. It also discusses the role of phospholamban in human heart failure and recent attempts to restore SR function in experimentally induced and human heart failure, which may be translated into future therapeutic approaches in the treatment of this disease.
引用
收藏
页码:572 / 578
页数:7
相关论文
共 51 条
[1]
Na-Ca exchange and Ca fluxes during contraction and relaxation in mammalian ventricular muscle [J].
Bers, DM ;
Bassani, JWM ;
Bassani, RA .
SODIUM-CALCIUM EXCHANGE: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE, 1996, 779 :430-442
[2]
INTRACELLULAR CALCIUM HANDLING IN ISOLATED VENTRICULAR MYOCYTES FROM PATIENTS WITH TERMINAL HEART-FAILURE [J].
BEUCKELMANN, DJ ;
NABAUER, M ;
ERDMANN, E .
CIRCULATION, 1992, 85 (03) :1046-1055
[3]
DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[4]
Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban [J].
Brittsan, AG ;
Carr, AN ;
Schmidt, AG ;
Kranias, EG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :12129-12135
[5]
Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts [J].
Chu, GX ;
Luo, WS ;
Slack, JP ;
Tilgmann, C ;
Sweet, WE ;
Spindler, M ;
Saupe, KW ;
Boivin, GP ;
Moravec, CS ;
Matlib, MA ;
Grupp, IL ;
Ingwall, JS ;
Kranias, EG .
CIRCULATION RESEARCH, 1996, 79 (06) :1064-1076
[6]
Dash R, 1999, CIRCULATION, V100, P419
[7]
Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a [J].
del Monte, F ;
Harding, SE ;
Schmidt, U ;
Matsui, T ;
Kang, ZB ;
Dec, W ;
Gwathmey, JK ;
Rosenzweig, A ;
Hajjar, RJ .
CIRCULATION, 1999, 100 (23) :2308-2311
[8]
The sarcoplasmic reticulum and the Na+Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes [J].
Dipla, K ;
Mattiello, JA ;
Margulies, KB ;
Jeevanandam, V ;
Houser, SR .
CIRCULATION RESEARCH, 1999, 84 (04) :435-444
[9]
Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction - Comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter [J].
Eizema, K ;
Fechner, H ;
Bezstarosti, K ;
Schneider-Rasp, S ;
van der Laarse, A ;
Wang, H ;
Schultheiss, HP ;
Poller, WC ;
Lamers, JMJ .
CIRCULATION, 2000, 101 (18) :2193-2199